Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)
CUSIP: 74365A309
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 80,361,978
- Total 13F shares
- 2,921,778
- Share change
- -1,495,829
- Total reported value
- $2,436,675
- Put/Call ratio
- 106%
- Price per share
- $0.83
- Number of holders
- 24
- Value change
- -$1,654,962
- Number of buys
- 8
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74365A309:
Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Dexcel Pharma Technologies Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,637,314
|
$5,128,613 | — | 02 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
2.8%
|
2,285,025
|
$3,039,000 | — | 30 Sep 2021 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.32%
|
254,871
|
$339,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.31%
|
251,171
|
$334,000 | — | 30 Sep 2021 | |
| MEITAV INVESTMENT HOUSE LTD |
13F
|
Company |
0.3%
|
244,332
|
$325,000 | — | 30 Sep 2021 | |
| Phoenix Financial Ltd. |
13F
|
Company |
0.3%
|
244,113
|
$325,000 | — | 30 Sep 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.28%
|
222,553
|
$296,000 | — | 30 Sep 2021 | |
| Walleye Capital LLC |
13F
|
Company |
0.27%
|
220,089
|
$293,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.15%
|
119,555
|
$159,000 | — | 30 Sep 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.09%
|
69,049
|
$129,000 | — | 30 Sep 2021 | |
| Walleye Trading LLC |
13F
|
Company |
0.1%
|
81,000
|
$108,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.07%
|
59,500
|
$79,000 | — | 30 Sep 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
58,890
|
$78,000 | — | 30 Sep 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
40,949
|
$54,000 | — | 30 Sep 2021 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.04%
|
36,000
|
$48,000 | — | 30 Sep 2021 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0.04%
|
33,200
|
$44,000 | — | 30 Sep 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.04%
|
31,974
|
$43,000 | — | 30 Sep 2021 | |
| WOLVERINE TRADING, LLC |
13F
|
Company |
0.04%
|
28,168
|
$39,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
24,945
|
$34,000 | — | 30 Sep 2021 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
20,514
|
$27,000 | — | 30 Sep 2021 | |
| Spire Wealth Management |
13F
|
Company |
0.02%
|
18,000
|
$24,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
14,200
|
$19,000 | — | 30 Sep 2021 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.01%
|
11,267
|
$14,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
8,890
|
$12,000 | — | 30 Sep 2021 | |
| Psagot Value Holdings Ltd. |
13F
|
Company |
0.01%
|
6,000
|
$8,000 | — | 30 Sep 2021 | |
| Psagot Value Holdings Ltd. / (Israel) |
13F
|
Company |
0.01%
|
6,000
|
$8,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
5,847
|
$8,000 | — | 30 Sep 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
5,761
|
$8,000 | — | 30 Sep 2021 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
0%
|
4,000
|
$5,000 | — | 30 Sep 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
3,000
|
$4,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,194
|
$3,000 | — | 30 Sep 2021 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1,100
|
$1,463 | — | 30 Sep 2021 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1,000
|
$1,000 | — | 30 Sep 2021 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0%
|
800
|
$1,000 | — | 30 Sep 2021 | |
| Ten Capital Wealth Advisors, LLC |
13F
|
Company |
0%
|
552
|
$1,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
500
|
$1,000 | — | 30 Sep 2021 |
Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q4 2021
As of 31 Dec 2021,
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,921,778 shares.
The largest 10 holders included
MORGAN STANLEY, GROUP ONE TRADING, L.P., Phoenix Holdings Ltd., Spire Wealth Management, BlackRock Inc., TWO SIGMA ADVISERS, LP, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and COMMONWEALTH EQUITY SERVICES, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
32
Q4 2021 holders
24
Holder diff
-8
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.